Augmenix Receives $6,000,000 Series E Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e5da211-298c-4986-b05a-25f89c2a8ad9
Date
7/14/2016
Company Name
Augmenix
Mailing Address
204 2nd Avenue Lower Level Waltham, MA 02451 USA
Company Description
Augmenix’s hydrogel technology improves outcomes in prostate radiation oncology and surgery. Learn more about the SpaceOAR system.
Website
http://www.augmenix.com
Transaction Type
Venture Equity
Transaction Amount
$6,000,000
Transaction Round
Series E
Proceeds Purposes
This infusion of capital will allow Augmenix to focus on next-generation products and build on significant growth driven by the robust commercial uptake of its innovative SpaceOAR System.
M&A Terms
Venture Investor
Undisclosed